Molina Healthcare of Illinois

Similar documents
HEDIS Provider Manual

HEDIS TOOLKIT FOR PROVIDER OFFICES. A Guide to Understanding Medicaid Measure Compliance

HEDIS 101 for Providers 2018

BHNNY PPS Phase Three Pay for Performance Measures. Measure Specification & Improvement Resource Guide

HEDIS Measures and the Family Physician Office. Pablo J Calzada DO, MPH, FAAFP, FACOFP

Patient Centered Medical Home 2011 Standards

Quality Improvement Program (QIP) Measurement Specifications

At the start of each HEDIS season, you will receive a fax from L.A. Care. Each fax request will stipulate what documents need to be faxed back.

June Thank you for attending today s Webinar. We will begin shortly. June Brian Clark. Diana Charlton. Debbie Barkley Aetna Inc.

Medicare & MMP HEDIS Toolkit

HEDIS. Provider Manual. McLarenHealthPlan.org

2018 Practice Improvement Program (PIP) Orientation. January 4 th, 2018 San Francisco Health Plan Practice Improvement Program (PIP)

and HEDIS Measures

Developmental Screening Focus Study Results

KSPEC HEDIS Benchmarks and Coding Guidelines for Quality Care

IAPEC HEDIS Benchmarks and Coding Guidelines for Quality Care

Gateway to Practitioner Excellence GPE 2017 Medicaid & Medicare

2016 EPSDT. Program Evaluation. Our mission is to improve the health and quality of life of our members

Benchmarks and Coding Guidelines for Quality Care

HEDIS 101 for Providers

Practice Improvement Program 2017 Program Guide Primary Care

AETNA BETTER HEALTH OF NEW JERSEY 2017 Quality Incentive Program

Provider Engagement Tool Kit

2017 EPSDT. Program Evaluation. Our mission is to improve the health and quality of life of our members

QUALITY IMPROVEMENT. Articles of Importance to Read: Quality Improvement Program. Winter Pages 1, 2, 3, 4 and 5 Quality Improvement

Healthcare Effectiveness Data and Information Set (HEDIS)

Payment Transformation 2018 Measure Changes and Updates. April 4, 2018

HEDIS Provider Guide & Toolkit

ProviderReport. Managing complex care. Supporting member health.

Please stand by. There is no audio being streamed right now. We are doing a audio/sound check before we begin the presentation 10/28/2015 1

Quality: Finish Strong in Get Ready for October 28, 2016

Quality Measurement Approaches of State Medicaid Accountable Care Organization Programs

HEDIS July Report the Care You Give It Pays!

2012 QUALITY ASSURANCE ANNUAL REPORT Executive Summary

Falcon Quality Payment Program Checklist- 2017

HouseCalls Objectives

Fast Facts 2018 Clinical Integration Performance Measures

Update Report: 2013 Medi-Cal 30 Day All-Cause Hospital Readmission Collaborative Project

Integration Workgroup: Bi-Directional Integration Behavioral Health Settings

IHCP Annual Workshop October 2017

MDwise Pay-for-Performance (HEDIS)

Molina Healthcare of Ohio Marketplace Plans

Summary of Measures, Product Lines and Changes

Instructions for Accessing the Secure Portal and the Verification Process

HEDIS Updates to quality ratings, measures & reporting. Wilhelmina Delostrinos, Director of Quality Improvement & Accreditation

QUALITY IMPROVEMENT PROGRAM

Communicator. the JUST A THOUGHT. Ensuring HEDIS-Compliant Preventive Health Services. Provider Portal Features. Peer-to-Peer Review BY DR.

Meaningful Use Measures: Quick Reference Guide Stage 2 (2014 and Beyond)

Medi-Cal Performance Measurement: Making the Leap to Value-Based Incentives. Dolores Yanagihara IHA Stakeholders Meeting October 3, 2018

Arkansas Blue Cross and Blue Shield Patient Centered Medical Home Provider Manual

Tennessee Health Care Innovation Initiative

Practice Improvement Program 2014 Program Guide

Technical Specifications Community Checkup Measures About the technical specifications Measures sourced from the Washington Health Alliance Database

Chapter 7. Unit 2: Quality Performance Measures

KanCare All MCO Training Physicians and Specialists Spring 2018

Meaningful Use and PCC EHR

NEWS July Clinical Practice & Preventive Health Guidelines. Community Outreach Events

QUALITY IMPROVEMENT. Molina Healthcare has defined the following goals for the QI Program:

Federally Qualified Health Centers Rural Health Clinics. February Interim. Pay for. Quality

2018 PROVIDER TOOLKIT

Patient-centered medical homes (PCMH): Eligible providers.

Total Cost of Care Technical Appendix April 2015

Table of Contents. ii 2016 New Jersey HMO & PPO Performance Report

For more information on any of the topics covered, please visit our provider self-service website at

PPC2: Patient Tracking and Registry Functions

Patient-centered medical homes (PCMH): eligible providers.

TO BE RESCINDED Patient-centered medical homes (PCMH): eligible providers.

Assistance. Improving. Consumer Health. Strategies for

The Florida KidCare Program Evaluation

Quality Measures for HMO s: Understanding HEDIS

Anthem Blue Cross and Blue Shield

2017 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members

CLINICAL PRACTICE EVALUATION II: CLINICAL SYSTEMS REVIEW

Provider Training Quality Enhancement 2016

Chapter 2 Provider Responsibilities Unit 5: Specialist Basics

Goals & Challenges for Outpatient Quality Directors. Quality HealthCare Consulting, LLC CEO: Jennifer O'Donnell, MHA, PCMH-CCE

Medical Record Review Tool Standards with Definitions

Benchmark Data Sources

Passport Advantage Provider Manual Section 8.0 Quality Improvement

Important RMHP Pharmacy Change for 2016

Medical Management. G.2 At a Glance. G.2 Procedures Requiring Prior Authorization. G.3 How to Contact or Notify Medical Management

In This Issue. Issue: 8. Codes Utilization FAQs Harry s Health Highlights. Who s Harry? HEDIS News

Medical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management

Positioning FQHCs for Value-Based Payment Arrangements

ALL NEW ALOHACARE WEBSITE

Coding Coach Coding Tips

Arkansas Blue Cross and Blue Shield Patient Centered Medical Home Provider Manual

Accountable Care and the Laboratory Value Proposition. Les Duncan Director of Operations Highmark Health - Home and Community Services

IMPROVING THE QUALITY OF CARE IN SOUTH CAROLINA S MEDICAID PROGRAM

October 2, Dear Colleague:

Florida Medicaid: Performance Measures (HEDIS)

ALOHACARE CHANGE IN REFERRAL POLICY

ATTACHMENT II EXHIBIT II-C Effective Date: February 1, 2018 CHRONIC DISEASE SPECIALTY PLAN

ICHP : Department of Health Care Policy & Financing Updates

October 2, Dear Colleague:

Payment Transformation: Essentials of Patient Attribution An Introduction for Internal Staff

Quality Improvement Program Evaluation

United Medical ACO Participation Criteria

A Publication for Molina Healthcare Members Spring 2005

PREVENTIVE MEDICINE AND SCREENING POLICY

Transcription:

Molina Healthcare of Illinois HEDIS CODING BOOKLET 2018

Page Number Tools for Success 3 What is HEDIS? 3 How Molina Uses Your HEDIS Scores? 3 HEDIS Measures of Focus 5-6 HEDIS Measures Sheets - Child/Adolescent Preventive Health 7 HEDIS Measures Sheets Chronic Conditions 15 HEDIS Measures Sheets- Adult Preventive Health 20 HEDIS Measure Sheets Women s Preventive Health 25 HEDIS Measure Sheets Behavioral Health 31 HEDIS Measure Sheets Older Preventive Health 37 HEDIS Measure Sheets Respiratory Health 41 Partnering with Molina 45 Next Steps 46 Key Terms and Acronyms 47

Tools for Success Welcome to the Molina Healthcare of Illinois Healthcare Effectiveness Data and Information Set (HEDIS ) Booklet! This guide is designed to help your practice: Increase your HEDIS performance scores Understand the coding that will provide evidence of services rendered for your patients and improve Quality Incentive Program earnings potential through the use of HEDIS reference sheets that include: Measures description Age range Billing codes for each measure Increase your working knowledge about the HEDIS measure requirements Provide helpful tips to improve chart documentation What is HEDIS? Healthcare Effectiveness Data and Information Set (HEDIS ) is a set of standardized performance measures developed by the National Committee for Quality Assurance (NCQA) to objectively measure, report, and compare quality across health plans. NCQA develops HEDIS measures through a committee represented by purchasers, consumers, health plans, health care providers, and policy makers. As state and federal governments move toward a quality-driven healthcare industry, HEDIS rates are becoming more important for both health plans and individual providers. State purchasers of aggregate HEDIS rates to evaluate health insurance companies efforts to improve preventive health outreach for Members. Provider-specific scores are also used to measure your practice s preventive care efforts. Your practice s HE- DIS score determines your rates for provider incentive programs that pay you an increased premium for example the Quality Incentive Program. Why does Molina use your HEDIS scores? Molina collects data for and reports on HEDIS measures to achieve the following outcomes: Meet the State of Illinois Department of Healthcare and Family Services (HFS) regulatory requirements to report performance data annually and at more frequent intervals to ensure quality care and services are being provided to our health plan Members by contracted providers Per Medicaid contractual requirements maintain National Committee for Quality Assurance (NCQA) accreditation status with the ultimate goal of achieving Excellent status Completion of reporting requirements, for the Centers for Medicare and Medicaid Services (CMS) Increased enrollment to the health plan through the provision of metrics and guidance for Medicaid beneficiaries to do an apples-to-apples comparison of health plans to help them determine which Medicaid health plan is best for them Return of withhold funds set aside by the state to improve plan operations and provision of services to Members (Impacts FHP/ ACA, ICP and MMP/MMAI populations)

HEDIS data collection methods HEDIS rates can be collected in two ways: Administrative and hybrid data collection. Administrative data: Administrative data collection consists of information from claims or encounter data submitted to the health plan. The calculated metric is based solely on data from these sources. Hybrid data: Hybrid data is a combination of data obtained through review of a random sample of Member medical records and administrative data. Medical records are abstracted for services rendered but that were not reported to the health plan through claims/encounter data. This abstracted data is combined with administrative data to create a hybrid metric.

HEDIS measures of focus Area of Focus Measure Measure HealthChoice MMP Key Adult Preventive Adults' Access to Preventive/Ambulatory AAP X X Health Health Services Adult BMI Assessment ABA X X Behavioral Health Antidepressant Medication Management AMM X X Child/Adolescent Preventive Health Chronic Conditions Older Adult Preventive Health Initiation and Engagement of Alcohol and IET X X Other Drug Dependency Treatment Follow-Up After Hospitalization for Mental FUH X X Illness Diabetes Screening for People with Schizophrenia SSD X X or Bipolar Disorder Who are Using Antipsychotic Medications Follow-Up for Children Prescribed ADHD Medication ADD X Children and Adolescents Access to Primary CAP X - Care Practitioners Well-Child Visits in the First 15 Months of Life W15 X - 6+ visits Childhood Immunization Status - Combo 10 CIS X Well-Child Visits in the 3rd, 4th, 5th, and 6th W34 X Years of Life Adolescent Well-Care Visits AWC X Immunizations for Adolescents - Combo 2 IMA X Weight Assessment and Counseling for Nutrition and Physical Activity for Children/ Adolescents WCC X Comprehensive Diabetes Care CDC X X Controlling High Blood Pressure CBP X X Statin Therapy for Patients with Diabetes SPD X X Annual Monitoring for Patients on Persistent MPM X X Medications Care for Older Adults COA X Respiratory Health Women's Preventive Health Osteoporosis Management in Women Who Had a Fracture OMW X Colorectal Cancer Screening COL X Medication Management for People with MMA X X Asthma - 75% Compliance Use of Spirometry Testing in the Assessment SPR X X and Diagnosis of COPD Pharmacotherapy for Management of COPD PCE X X Exacerbation - Bronchodilators Pharmacotherapy for Management of COPD PCE X X Exacerbation - Systemic Corticosteroid Breast Cancer Screening BCS X X Cervical Cancer Screening CCS X Chlamydia Screening in Women CHL X Timeliness of Prenatal Care PPC X Postpartum Care PPC X

HEDIS measures of focus Please continue reading to find all measures mentioned in the tables above. The following HEDIS reference sheets include: Measures description Age range

HEDIS Sheets Child/Adolescent Preventive Health Children and Adolescents Access to Primary Care Practitioners Well-Child Visits in the First 15 Months Life 6+ visits Childhood Immunization Status Combo 10 Well-Child Visits in the 3 rd, 4 th, 5 th, and 6 th Years of Life Adolescent Well-Care Visits Immunizations for Adolescents Combo 2 Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents

Children and Adolescents Access to Primary Care Practitioners The percentage of patients 12 months to 19 years of age who had a visit with a PCP. Four separate percentages are reported for each product line. Children 12 to 24 months and 25 months to six (6) years who had a visit with a PCP during the measurement year. Children seven (7) to 11 years and adolescents 12 to 19 years who had a visit with a PCP during the measurement year or the year prior to the measurement year. Codes to Identify Ambulatory or Preventive Care Visits Ambulatory Visits Codes *ICD-9: V20.2, V70.0, V70.3, V70.5, V70.6, V70.8,V70.9 ICD-10: Z00.00, Z00.01, Z00.121, Z00.129, Z00.5, Z00.8, Z02.0-Z02.6, Z02.71, Z02.79, Z02.81-Z02.83, Z02.89, Z02.9 CPT: 99201-99205, 99211-99215, 99241-99245, 99341-99345, 99347-99350, 99381-99387, 99391-99397, 99401 HCPCS: G0438, T1015 UBREV: 0510-0517, 0519-0523, 0526-0529, 0982, 0983 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Avoid missed opportunities by taking advantage of every office visit (including sick visits) to provide an ambulatory or preventive care visit. Make sports/day care physicals into ambulatory or preventive care visits by performing the required services and submitting appropriate codes. Include the date when a health and developmental history and physical exam was performed and health education/anticipatory guidance was given in the medical record. Use standardized templates in charts and in EMRs that allow checkboxes for standard counseling activities. Updated 2/27/2018

Well-Child Visits First 15 Months of Life Children who turned 15 months old during the measurement year and who had at least six (6) wellchild visits with a PCP prior to turning 15 months. Well-child visits consists of all of the following: A health history A physical developmental history A mental developmental history A physical exam Health education/anticipatory guidance Codes Well-Child Visits CPT: 99381-99385, 99391-99395, 99461 HCPCS: G0438 ICD-9: V20.2, V20.31, V20.32, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9 *ICD-10: Z00.110, Z00.111, Z00.121, Z00.129, Z00.5, Z00.8, Z02.0.2-Z02.6, Z02.71, Z02.79, Z02.81-Z02.83, Z02.89, Z02.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Avoid missed opportunities by taking advantage of every office visit (including sick visits) to provide a well-child visit, immunizations, and lead testing. Make day care physicals into well-care visits by performing the required services and submitting appropriate codes. Medical record needs to include the date when a health and developmental history and physical exam was performed and health education/anticipatory guidance was given. Use standardized templates in charts and in EMRs that allow checkboxes for standard counseling activities. Updated 2/27/18

Childhood Immunization Status Children two (2) years of age who had the following vaccines on or before their second birthday: Four DTaP (diphtheria, tetanus and acellular pertussis) Three IPV (polio) One MMR (measles, mumps, rubella) Three HiB (H influenza type B) Three HepB (hepatitis B) One VZV (chicken pox) Four PCV (pneumococcal conjugate) One HepA (hepatitis A) Two or Three RV (rotavirus) Two Influenza (flu) Codes to Identify Childhood Immunizations DTaP IPV MMR Measles and rubella CVX: 04 Measles CVX: 05 Mumps CVX: 07 Rubella CVX: 06 HiB Hepatitis B Newborn Hepatitis B CPT/HCPCS/ICD/CVX Codes CPT: 90698, 90700, 90723 CVX: 20, 50, 106,107,110, 120 CPT: 90698, 90713, 90723 CVX: 10, 89, 110, 120 CPT: 90707, 90710 CVX: 03, 94 CPT: 90644 90647,90648, 90698 CVX: 17, 46-51, 120, 148 CPT: 90723, 90740, 90744, 90747, 90748 HCPCS: G0010, CVX: 08, 44, 45 51, 110 *ICD-9: 99.55; ICD-10: 3E0234Z VZV CPT: 90710, 90716 CVX: 21, 94 Pneumococcal conjugate CPT: 90670 CVX: 100, 133, 152 HCPCS: G0009 Hepatitis A CPT: 90633 CVX: 31,83,85 Rotavirus (two-dose schedule) Rotavirus (three-dose schedule) CPT: 90681 CVX: 119 CPT: 90680 CVX: 116, 122 Influenza CPT: 90662, 90673, 90685, 90687, 90688 CVX: 88, 135, 140, 141, 150, 153, 155, 161 HCPCS: G0008 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Use the State immunization registry. Review a child s immunization record before every visit and administer needed vaccines. Recommend immunizations to parents. Parents are more likely to agree with vaccinations when supported by the provider. Address common misconceptions about vaccinations, e.g., MMR causes autism (now completely disproven). Have a system for patient reminders. Some vaccines may have been given before patients were Molina Members. Include these on the Members vaccination record even if your office did not provide the vaccine. Updated 2/26/2018

Well-Child Visits 3 6 Years Children three (3) to six (6) years of age who had one or more well-child visits with a PCP during the measurement year. Well-child visits consists of all of the following: A health history A physical developmental history A mental developmental history A physical exam Health education/anticipatory guidance Well-Child Visits CPT: 99381-99385 99391-99395 99461 HCPCS: G0438 Codes ICD-9: V20.2, V20.31, V20.32, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9 *ICD-10: Z00.110, X00.11, Z00.121, Z00.129, Z00.5, Z00.8, Z02.0-Z02.6, Z02.71, Z02.79, Z02.81-Z02.83, Z02.89, Z02.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Avoid missed opportunities by taking advantage of every office visit (including sick visits) to provide a well-child visit, immunizations, and BMI percentile calculations. Make sports/day care physicals into well-care visits by performing the required services and submitting appropriate codes. Include the date when a health and developmental history and physical exam was performed and health education/anticipatory guidance was given in the medical record. Use standardized templates in charts and in EMRs that allow checkboxes for standard counseling activities. Updated 2/27/18

Adolescent Well-Care Visit Patients 12-21 years of age who had one comprehensive well-care visit with a PCP or OB/GYN during the measurement year. Well-care visit consists of all of the following: A health history A physical developmental history A mental developmental history A physical exam Health education/anticipatory guidance Well-Care Visits Codes CPT: 99381-99385, 99391-99395, 99461 HCPCS: G0438 ICD-9: V20.2, V20.31, V20.32, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9 *ICD-10: Z00.00, Z00.01, Z00.110, Z00.111, Z00.121, Z00.129, Z00.5, Z00.8, Z02.0-Z02.6, Z02.71, Z02.79, Z02.81-Z02.83, Z02.89, Z02.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Avoid missed opportunities by taking advantage of every office visit (including sick visits) to provide a well-care visit, immunizations, and BMI value/percentile calculations. Make sports/day care physicals into well-care visits by performing the required services and submitting appropriate codes. Include the date when a health and developmental history and physical exam was performed and health education/anticipatory guidance was given in the medical records. Use standardized templates in charts and in EMRs that allow checkboxes for standard counseling activities. Updated 2/27/18

Immunizations for Adolescents Adolescents 13 years of age who received the following vaccines on or before the 13 th birthday: One meningococcal conjugate vaccine (must be completed on or between the 11 th and 13 th birthdays) One Tdap or one tetanus, diphtheria toxoids and acellular pertussis (Tdap) (must be completed on or between the 10th and 13th birthdays) At least two Human Papillomavirus (HPV) vaccines or three HPV vaccines with different dates of service on or between the 9th and 13th birthdays Codes to Identify Adolescent Immunizations Meningococcal Tdap HPV CPT/CVX Codes CVX: 108,136, 147 CPT: 90715 CVX: 115 CPT: 90649,90650, 90651 CVX: 62,118, 137,165 Use the state immunization registry. Review missing vaccines with parents. Recommend immunizations to parents. Parents are more likely to agree with vaccinations when supported by the provider. Address common misconceptions about vaccinations. Train office staff to prep the chart in advance of the visit and identify overdue immunizations. Make every office visit count - take advantage of sick visits for catching up on needed vaccines. Institute a system for patient reminders. Some vaccines may have been given before patients were Molina Members. Include these on the Members vaccination record even if your office did not provide the vaccine. Administer the HPV vaccine at the same time as other vaccines. Inform parents that the full HPV vaccine series requires 2 or 3 shots and have a system for patient reminders. Recommend the HPV vaccine series the same way you recommend other adolescent vaccines. Parents are more likely to agree with vaccinations when supported by the provider. Address common misconceptions about the HPV vaccine. Updated 2/26/2018

Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents Children 3-17 years of age who had an outpatient visit with a primary care physician or OB/GYN and who had evidence of the following during the measurement year. BMI percentile documentation or BMI percentile plotted on age- growth chart (height, weight and BMI percentile must be documented) Counseling for nutrition or referral for nutrition education Counseling for physical activity or referral for physical activity BMI Percentile <5% for age BMI Percentile 5% to <85% for age BMI Percentile 85% to <95% for age BMI Percentile 95% for age Counseling for Nutrition Codes *ICD-9: V85.51 ICD-10: Z68.51 *ICD-9: V85.52 ICD-10: Z68.52 *ICD-9: V85.53 ICD-10: Z68.53 *ICD-9: V85.54 ICD-10: Z68.54 CPT: 97802-97804 *ICD-9: V65.3 ICD-10: Z71.3 HCPCS: G0270, G0271 Counseling for Physical Activity *ICD-9: V65.41 ICD-10: Z02.5 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Use appropriate HEDIS codes to avoid medical record review. Avoid missed opportunities by taking advantage of every office visit (including sick visits and sports physicals) to capture BMI percentile, counsel on nutrition and physical activity. Place BMI percentile charts near scales. When documenting BMI percentile, include height, weight and BMI percentile. When counseling for nutrition, document current nutrition behaviors (e.g. meal patterns, eating and dieting habits). Documentation related to a Member s appetite does not meet criteria. When counseling for physical activity document: o Physical activity counseling/education (e.g. child rides tricycle in yard). o Current physical activity behaviors (e.g. exercise routine, participation in sports activities and exam for sports participation). o While cleared for sports does not count, a sports physical does count. o Include specific mention of physical activity recommendations to meet criteria for notation of anticipatory guidance. Updated 2/23/2018

HEDIS Sheets Chronic Conditions Comprehensive Diabetes Care Controlling High Blood Pressure Statin Therapy for Patients with Diabetes Annual Monitoring for Patients on Persistent Medications

Comprehensive Diabetes Care Adults 18-75 years of age with diabetes (type1 and type 2) who had each of the following: Hemoglobin A1c (HbA1c) testing HbA1c poor control (>9.0%)* * a lower rate is better HbA1c control <8.0% Eye exam (retinal or dilated) performed BP control (<140/90 mmhg) Nephropathy monitoring - Nephropathy screening or monitoring test - Treatment for nephropathy or ACE/ARB therapy - Stage 4 CKD - ESRD - Kidney transplant - Visit with a nephrologist - ACE/ARB dispensed Codes to Identify HbA1c Tests Codes to Identify Blood Pressure Control Codes to Identify Nephropathy Screening Test (Urine Protein Tests) Codes to Identify Eye Exam (must be performed by optometrist or ophthalmologist) CPT: 83036, 83037 Codes CPT II: 3044F (if HbA1c <7%), 3045F (if HbA1c 7% - 9%), 3046F (if HbA1c >9%) CPT II: 3074F, 3075F (if systolic < 140) 3077F (if systolic 140) 3078F (if diastolic < 80) 3079F (if diastolic 80-89) 3080F (if diastolic 90) CPT: 81000-81003, 81005, 82042-82044, 84156 CPT II: 3060F, 3061F, 3062F CPT: 67028, 67030, 67031, 67036, 67039-67043, 67101, 67105, 67107, 67108, 67110, 67112, 67113, 67121, 67141, 67145, 67208, 67210, 67218, 67220, 67221, 67227, 67228, 92002, 92004, 92012, 92014, 92018, 92019, 92134, 92225-92228, 92230, 92235, 92240, 92250, 92260, 99203-99205, 99213-99215, 99242-99245 HCPCS: S0620, S0621, S3000 Codes to Identify Diabetes Codes *ICD-9: 250.00-250.93, 357.2, 362.01-362.07, 366.41, 648.00-648.04 ICD-10: E10, E11, E13, O24 Codes to Identify Diabetic Retinal Screening With Eye Care Professional billed by any provider CPT II: 2022F, 2024F, 2026F, 3072F *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Updated 2/23/2018 Review diabetes services needed at each office visit. Order labs prior to patient appointments. Bill for point of care testing if completed in office and Ensure HbA1c result and date are documented in the chart. Adjust therapy to improve HbA1c and BP levels; follow-up with patients to monitor changes. Make sure a digital eye exam, remote imaging, and fundus photography are read by an eye care professional (optometrist or ophthalmologist) so the results count. Use 3072F if member s eye exam was negative or showed low risk for retinopathy in the prior year. Prescribe statin therapy to all diabetics age 40 to 75 years. Refer patients for Health Management interventions and coaching by contacting Health Care Services at your affiliated Molina Healthcare State plan.

Controlling High Blood Pressure Patients 18 59 years of age who had a diagnosis of hypertension (HTN) and whose BP was adequately controlled (<140/90 mm Hg) during the measurement year. Patients 60-85 years of age who had a diagnosis of hypertension (HTN) and diabetes and whose BP was adequately controlled (<140/90 mm Hg) during the measurement year. Patients 60-85 years of age who had a diagnosis of hypertension (HTN) and whose BP was adequately controlled (<150/90 mm Hg) during the measurement year. Note: Patients are included in the measure if there was a claim/encounter with a diagnosis of hypertension on or before June 30 of the measurement year. Codes to Identify Hypertension *ICD-9 Code ICD-10 Code Hypertension 401.0, 401.9 I10 CPT Codes Hypertension 88141-88143 * ICD-9 codes are included for historical purposes only and can no longer be used for billing. Calibrate the sphygmomanometer annually. Upgrade to an automated blood pressure machine. Select appropriately sized BP cuff. Retake the BP if it is high at the office visit (140/90 mm Hg or greater) (HEDIS allows us to use the lowest systolic and lowest diastolic readings in the same day) and oftentimes the second reading is lower. Do not round BP values up. If using an automated machine, record exact values. Review hypertensive medication history and patient compliance, and consider modifying treatment plans for uncontrolled blood pressure, as needed. Have the patient return in 3 months. Start two BP drugs at first visit if initial reading is very high and is unlikely to respond to a single drug and lifestyle modification. Contact Molina Healthcare to address medication issues. Updated 2/23/2018

Statin Therapy for Patients with Diabetes Patients 40 75 years of age during the measurement year with diabetes who do not have clinical atherosclerotic cardiovascular disease (ASCVD) who met the following criteria. Two rates are reported: 1. Received Statin Therapy. Patients who were dispensed at least one statin medication of any intensity during the measurement year. 2. Statin Adherence 80 percent. Patients who remained on a statin medication of any intensity for at least 80 percent of the treatment period. High, Moderate and Low-Intensity Statin Prescriptions Prescription High-intensity statin therapy Moderate-intensity statin therapy Atorvastatin 40-80 mg Amlodipine-atorvastatin 40-80 mg Ezetimibe-atorvastatin 40-80 mg Atorvastatin 10-20 mg Amlodipine-atorvastatin 10-20 mg Ezetimibe-atorvastatin 10-20 mg Rosuvastatin 5-10 mg Simvastatin 20-40 mg Ezetimibe-simvastatin 20-40 mg Niacin-simvastatin 20-40 mg Rosuvastatin 20-40 mg Simvastatin 80 mg Ezetimibe-simvastatin 80 mg Sitagliptin-simvastatin 20-40 mg Pravastatin 40-80 mg Lovastatin 40 mg Niacin-Iovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2-4 mg Low-intensity statin therapy Simvastatin 10 mg Ezetimibe-simvastatin 10mg Sitagliptin-simvastatin 10 mg Pravastatin 10-20 mg Lovastatin 20 mg Niacin-lovastatin 20 mg Fluvastatin 20-40 mg Pitavastatin 1 mg *Please refer to the Molina Healthcare Drug Formulary at www.molinahealthcare.com for statin medications that may require prior authorization or step therapy. Educate patients on the following: o o o People with diabetes are two to four times more likely to develop heart disease or stroke. Statins can help reduce the chance of developing heart disease and strokes. Continue educating patients about the importance of adhering to their medication therapy and follow-up visits with their provider(s). o Strategies for remembering to take your medication. Schedule appropriate follow-up with patients to assess if medication is taken as prescribed. Do not rely on the patient to follow through with scheduling subsequent appointments. Routinely arrange the next appointment when the patient is in the office. If the patient misses a scheduled appointment, office staff should contact the patient to assess why appointment was missed. Contact Health Care Services at your affiliated Molina Healthcare state plan for additional information about Medication Therapy Management criteria and to request a referral for patients with at least six (6) chronic medications and at least three (3) qualifying diagnoses. They may be eligible for MTM sessions. Updated 2/27/2018

Annual Monitoring for Patients on Persistent Medications Adults 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. Annual monitoring for Members on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB): Need either a lab panel test or a serum potassium test and a serum creatinine test Annual monitoring for patients on diuretics: Need a lab panel test or a serum potassium test and a serum creatinine test Codes to Identify Therapeutic Monitoring CPT Codes Lab Panel 80047, 80048, 80053, 80069 Serum Potassium 80051, 84132 Serum Creatinine 82565, 82575 Schedule a follow-up visit when prescribing a new medication to your patient within 30 days to assess how the medication is working. Schedule this visit while your patient is still in the office. Schedule two more visits in the 5 months after the first 30 days to continue to monitor your patient s progress. Discuss different treatment options if the patient has any issues with the medication (if possible) or switch to an equivalent medication (e.g., ACE-I to ARB). Keep in mind that some medication exchanges between classes (e.g., ACE-I to calcium channel blocker in a diabetic patient) may be necessary in a few situations, but may not be generally recommended as routine practice. Ensure the patient is able to easily obtain the medication (i.e. mail-order prescription, if needed). Educate the patient on how they might be able to alleviate any medication side effects. Updated 2/27/2018

HEDIS Sheets Adult Preventive Health Adults Access to Preventive/Ambulatory Health Services Adult BMI Assessment

Adults Access to Preventive/Ambulatory Health Services Patients 20 years and older who had an ambulatory or preventive care visit during the measurement year. Codes to Identify Preventive/Ambulatory Health Services Codes Ambulatory Visits CPT: 99201-99205, 99211-99215, 99241-99245, 99341-99345, 99347-99350, 99381-99387, 99391-99397, 99401 HCPCS: G0438, T1015 *ICD-9: V20.2, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9 UB Rev: 0510-0517, 0519-0523, 0526-0529, 0982-0983 ICD-10: Z00.00, Z00.01, Z00.121, Z00.129, Z00.5, Z00.8, Z02.0-Z02.6, Z02.71, Z02.79, Z02.81, Z02.82, Z02.83, Z02.89, Z02.9 Other Ambulatory Visits CPT: 92002, 92004, 92012, 92014, 99304-99310, 99315, 99316, 99318, 99324-99328, 99334-99337 UB Rev: 0524, 0525 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Use appropriate billing codes as described above. Educate patients on the importance of having at least one ambulatory or preventive care visit during each calendar year. Contact patients on the needed services list who have not had a preventive or ambulatory health visit. Look into offering expanded office hours to increase access to care. Make reminder calls to patients who have appointments to decrease no-show rates. Updated 2/27/2018

AAP Visits and Billing Codes Ambulatory Visits Billing Code(s) New patient office visit CPT: 99201-99205 Established patient office visit with at least 2 of 3 key components: Problem focused history Problem focused examination Straightforward medical decision making Office consultation with new or established patient with at least 2 of 3 key components: Comprehensive history Comprehensive examination Medical decision making CPT: 99211-99215 CPT: 99241-99245 New patient home services CPT: 99341-99345 Established patient home services CPT: 99347-99350 Initial comprehensive preventive medicine evaluation and management CPT: 99381-99387 Periodic comprehensive preventive medicine reevaluation and management CPT: 99391-99397 Preventive medicine, individual counseling services CPT: 99401 Annual wellness visit, including a personalized prevention plan of service, initial visit Clinic visit/encounter, all-inclusive HCPCS: G0438 HCPCS: T1015 4

AAP Visits and Billing Codes cont d Other Ambulatory Visits Billing Code(s) New patient, general ophthalmological services and procedures CPT: 92002, 92004 Established patient, general ophthalmological services and procedures CPT: 92012, 92014 New or established patient, comprehensive nursing facility assessment CPT: 99304-99306 Subsequent nursing facility care CPT: 99307-99310 Nursing facility discharge services CPT: 99315, 99316 Other nursing facility services CPT: 99318 New patient domiciliary, rest home or custodial care services CPT: 99324-99328 Established patient domiciliary, rest home or custodial care services CPT: 99334-99337 4

Adult BMI Assessment Adults 18 74 years of age who had an outpatient visit and whose body mass index (BMI) or BMI percentile (for patients younger than 20 years) was documented during the measurement year or the year prior to the measurement year. For patients 20 years of age or older on the date of service, documentation in the medical record must indicate the weight and BMI value, dated during the measurement year or year prior to the measurement year. For patients younger than 20 years on the date of service, documentation in the medical record must indicate the height, weight and BMI percentile, dated during the measurement year or year prior to the measurement year. The following meets criteria for BMI percentile: BMI percentile documented as a value (e.g., 85th percentile) BMI percentile plotted on an age-growth chart Codes to Identify BMI ICD-9 Code* BMI <19, adult V85.0 ICD-10 Code BMI 19 or less, adult Z68.1 BMI between 19-24 adult V85.1 BMI between 20-24, adult Z68.20- Z68.24 BMI between 25-29, adult V85.21- V85.25 Z68.25- Z68.29 BMI between 30-39, adult V85.30- V85.39 Z68.30- Z68.39 BMI 40 and over, V85.41- adult V85.45 Z68.41- Z68.45 BMI, pediatric, <5th V85.51 percentile for age Z68.51 BMI, pediatric, 5th percentile to <85th V85.52 Z68.52 percentile for age BMI, pediatric, 85th percentile to <95th V85.53 Z68.53 percentile for age BMI, pediatric, 95th percentile for age V85.54 Z68.54 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Make BMI assessment part of the vital sign assessment at each visit. Use correct billing codes (decreases the need for us to request the medical record). Ensure proper documentation for BMI in the medical record with all components (i.e., date, weight, height, and BMI value). Provider signature must be on the same page. Update the EMR templates to automatically calculate a BMI if on an EMR. Calculate the BMI here if not on an EMR: http://www.cdc.gov/healthyweight/assessing/bmi/ Updated 2/26/2018

HEDIS Sheets Women s Preventive Health Breast Cancer Screening Cervical Cancer Screening Chlamydia Screening Prenatal Care Timeliness Postpartum Care

Breast Cancer Screening Measure Exclusion Codes: Bilateral Mastectomy Unilateral Mastectomy with a Bilateral Modifier or Two Unilateral Mastectomy Codes 14 days or more apart History of Bilateral Mastectomy ICD-10: Z90.13 Updated 2/26/2018 Women 50-74 years of age who had one or more mammograms any time on or between October 1 two (2) years prior to the measurement year and December 31 of the measurement year. Required Exclusion: Medicare patients age 65 and older as of January 1 of the measurement year who are enrolled in an institutional SNP or living long-term in an institution any time during the measurement year Optional Exclusion: Bilateral mastectomy Note: This measure evaluates primary screening. Do not count biopsies, breast ultrasounds, MRIs or tomosynthesis (3D mammography) because they are not appropriate methods for primary breast cancer screening. Breast Cancer Screening Codes CPT: 77063 HCPCS: G0202, G0204, G0206 *ICD-9: 87.36, 87.37 UB Revenue: 0401,0403 ICD-10: 0HTV0ZZ *ICD-9: 85.42, 85.44, 85.46, 85.48 Unilateral Mastectomy: CPT: 19303-19307 *ICD-9 Codes: 85.41, 85.43, 85.45, 85.41, 85.43, 85.45,85.47 Bilateral Modifier: CPT: 09950 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Educate female patients about the importance of early detection and encourage testing. Use needed services list to identify patients in need of mammograms. Document a bilateral mastectomy in the medical record and fax Molina Healthcare the chart. Schedule a mammogram for patient or send/give patient a referral/script (if needed). Have a list of mammogram facilities available to share with the patient (helpful to print on colored paper for easy reference). Discuss possible fears the patient may have about mammograms and inform women that currently available testing methods are less uncomfortable and require less radiation.

Cervical Cancer Screening Women 21-64 years of age who were screened for cervical cancer using either of the following criteria: Women age 21-64 who had cervical cytology during the measurement year or the two years prior to the measurement year. Women age 30-64 who had cervical cytology and human papillomavirus (HPV) co-testing performed during the measurement year or the four years prior to the measurement year. Exclusions: Women who had a hysterectomy with no residual cervix, cervical agenesis or acquired absence of cervix. Codes to Identify Cervical Cancer Screening Codes CPT: 88141-88143, 88147, 88148, 88150, 88152-88154, 88164-88167, 88174, 88175 Cervical Cytology HCPCS: G0123, G0124, G0141, G0143-G0145, G0147, G0148, P3000, P3001 UB Revenue: 0923 HPV Tests CPT: 87624, 87625 Measure Exclusion Codes CPT: 51925, 57540, 57545, 57550, 57555, 57556, 58150, 58152, 58200, 58210, 58240, 58260, 58262, 58263, 58267, 58270, 58275, 58280, 58285, 58290-58294, 58548, 58550, 58552-58554, 58570, 58571-58573, 58951, 58953, 58954, 58956, Absence of Cervix 59135 ICD-10: Q51.5, Z90.710, Z90.712, 0UTC0ZZ, 0UTC4ZZ, 0UTC7ZZ, 0UTC8ZZ, *ICD-9: 618.5, 752.43, V88.01, V88.03, 68.41, 68.49, 68.51, 68.59, 68.61, 68.69, 68.71, 68.79, 68.8 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Use needed services lists to identify women who need a Pap test. Use a reminder/recall system (e.g., tickler file). Request to have results of Pap tests sent to you if done at OB/GYN visits. Document in the medical record if the patient has had a hysterectomy with no residual cervix and fax Molina the chart. Remember synonyms total, complete, radical. Don t miss opportunities e.g., completing Pap tests during regularly-scheduled well woman visits, sick visits, urine pregnancy tests, UTI, and chlamydia/sti screenings. Updated 2/26/2018

Chlamydia Screening in Women Women 16-24 years of age who were identified as sexually active and who had at least one chlamydia test during the measurement year. Codes to Identify Chlamydia Screening CPT Code Exclusion: Patients who were included in the measure based on pregnancy test alone and the Member had a prescription for isotretinoin or an X-ray on the date of the pregnancy test or the six days after the pregnancy test. Chlamydia Tests 87110, 87270, 87320, 87490-87492, 87810 Perform chlamydia screening every year on every 16-24 year old female identified as sexually active (use any visit opportunity). Add chlamydia screening as a standard lab for women 16-24 years old. Use well-child exams and well women exams for this purpose. Ensure that you have an opportunity to speak with your adolescent female patients without her parent. Remember that chlamydia screening can be performed through a urine test. Offer this as an option for your patients. Place chlamydia swab next to Pap test or pregnancy detection materials. Updated 2/26/2018

Prenatal care visit in the first trimester or within 42 days of enrollment. Prenatal care visit, where the practitioner type is an OB/GYN or other prenatal care practitioner or PCP*, with one of these: HEDIS Tips: Prenatal Care Timeliness Basic physical obstetrical exam that includes auscultation for fetal heart tone, or pelvic exam with obstetric observations, or measurement of fundus height (a standardized prenatal flow sheet may be used) Obstetric panel Ultrasound of pregnant uterus Pregnancy-related diagnosis code (For visits to a PCP, a diagnosis of pregnancy must be present) TORCH antibody panel (Toxoplasma, Rubella, Cytomegalovirus, and Herpes simplex testing) Rubella antibody test/titer with an Rh incompatibility (ABO/Rh) blood typing (e.g., a prenatal visit with rubella and ABO, a prenatal visit with rubella and Rh, or a prenatal visit with rubella and ABO/Rh) Documented LMP or EDD with either a completed obstetric history or prenatal risk assessment and counseling/education * For visits to a PCP, a diagnosis of pregnancy must be present along with any of the above. Please note that global billing or bundling codes do not provide specific date information to count towards this measure. Prenatal Care Visits Obstetric Panel CPT: 80055, 80081 Codes CPT: 99201-99205, 99211-99215, 99241-99245 CPT II: 0500F, 0501F, 0502F HCPCS: H1000, T1015, UB Rev: 0514 CPT: 76801, 76805, 76811, 76813, 76815-76821, 76825-76828 Prenatal Ultrasound *ICD-9 Procedure: 88.78 ICD-10 PCS: BY49ZZZ, BY4BZZZ, BY4CZZZ, BY4DZZZ, BY4FZZZ, BY4GZZZ ABO and Rh CPT (ABO): 86900 CPT (Rh): 86901 CPT (Toxoplasma): 86777, 86778 CPT (Rubella): 86762 TORCH CPT (Cytomegalovirus): 86644 CPT (Herpes Simplex): 86694, 86695, 86696 *ICD-9 Diagnosis: 640.x3, 641.x3, 642.x3, 643.x3, 644.x3, 645.x3, 646.x3, 647.x3, Pregnancy Diagnosis 648.x3, 649.x3, 651.x3, 652.x3, 653.x3, 654.x3, 655.x3, 656.x3, 657.x3, 658.x3, 659.x3, (for PCP, use these 678.x3, 679.x3, V22-V23, V28 codes and one of the ICD-10: O09-O16, O20-O26, O28-O36, O40-O48, O60.0, O71, O88, O91, O92, O98, codes above) O99, O9A, Z03.7, Z33, Z34, Z36 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Schedule prenatal care visits starting in the first trimester or within 42 days of enrollment. Ask front office staff to prioritize new pregnant patients and ensure prompt appointments for any patient calling for a pregnancy visit to make sure the appointment is in the first trimester or within 42 days of enrollment. Have a direct referral process to OB/GYN in place. Complete and submit Molina s pregnancy notification as soon as a pregnancy diagnosis is confirmed. Refer Molina patients to our Motherhood Matters program. Updated 2/26/2018

Postpartum Care Postpartum visit for a pelvic exam or postpartum care with an OB/GYN practitioner or midwife, family practitioner or other PCP on or between 21 and 56 days after delivery. A Pap test within 21-56 days after delivery also counts. Documentation in the medical record must include a note with the date when the postpartum visit occurred and one of the following: Pelvic exam, or Evaluation of weight, BP, breast and abdomen, or Notation of postpartum care, PP check, PP care, 6-week check, or pre-printed Postpartum Care form in which information was documented during the visit Please note that global billing or bundling codes do not provide specific date information to count towards this measure. Codes to Identify Postpartum Visits Codes Postpartum Visit CPT: 57170, 58300, 59430 CPT II: 0503F HCPCS: G0101 ICD-10-CM Diagnosis: Z01.411, Z01.419,Z01.42, Z30.430, Z39.1, Z39.2 Codes to Identify Cervical Cytology Codes Cervical Cytology CPT: 88141-88143, 88147, 88148, 88150, 88152-88154, 88164-88167, 88174, 88175 HCPCS: G0123, G0124, G0141, G0143-G0145, G0147, G0148, P3000, P3001 UB Rev: 0923 Schedule your patient for a postpartum visit within 21 to 56 days from delivery (please note that staple removal following a cesarean section does not count as a postpartum visit for HEDIS ). Use the postpartum calendar tool from Molina to ensure the visit is within the correct time frames. Updated 2/27/18

HEDIS Sheets Behavioral Health Follow-up After Hospitalization for Mental Illness Initiation and Engagement of Alcohol and Other Drug Dependency Treatment Follow-Up for Children Prescribed ADHD Medication Antidepressant Medication Management Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who are Using Antipsychotic Medications

Follow-up After Hospitalization for Mental Illness Patients 6 years of age and older who were hospitalized for treatment of selected mental health diagnoses and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner within seven and 30 days of discharge. Visits must occur after the date of discharge. Follow-up Visits Codes to Identify Follow-up Visits (must be with mental health practitioner) Codes CPT: 99201-99204 Telehealth Modifier: GT HCPCS: H0002, H0004, H0031, H0039, H0040, H2010, H2011, H2015, H2017, S0201, S9480 UB Rev (visit in a non-behavioral health setting): 0510, 0515-0516, 0521, 0522, 0528 Follow-up Visits CPT: 90791, 90792, 90832-90834, 90836-90840, 90847, 90849, 90853, 90870 Telehealth Modifier: GT Codes WITH CPT: 99221-99223, 99231-99233 Telehealth Modifier: GT WITH POS: 52, 53 POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 24, 33, 49, 50, 52, 53, 71, 72 The literature indicates that during the first seven days post-discharge the patient is at greater risk for rehospitalization and, within the first three weeks post-discharge the risk of self-harm is high. Ensure that the follow-up appointment is made before the patient leaves the hospital and is scheduled within seven days of discharge. Contact Molina case management if assistance is needed to obtain follow-up appointment. Assist the patient with navigation of barriers, such as using their transportation benefit to get to their follow-up appointment. Ensure your patient has an understanding of the local community support resources and what to do in an event of a crisis. Review medications with patients to ensure they understand the purpose and appropriate frequency and method of administration. Ensure accurate discharge dates and document not just appointments scheduled, but appointments kept. Visits must be with a mental health practitioner. Provide information about the importance of monitoring their emotional well-being and following up with their mental health practitioner. Follow-up visits must be supported by a claim, encounter or note from the mental health practitioner s medical chart. Updated 1/5/18

Initiation & Engagement of Alcohol & Other Drug Abuse or Dependence Treatment The percentage of adolescent and adult patients 13 years of age and older with a new episode of alcohol or other drug (AOD) abuse or dependence with the following: Initiation of AOD Treatment. Initiate treatment through inpatient AOD admission, outpatient visit, intensive outpatient encounter or partial hospitalization, telehealth, or medication assisted treatment (MAT) within 14 days of diagnosis. Engagement of AOD Treatment. Initiated treatment and had two or more additional AOD services or MAT within 34 days of the initiation visit. Codes to Identify AOD Dependence CPT HCPCS UB Revenue 98960-98962, 98966-98969, 99078, 99201-99205, 99211-99215, 99217-99220, 99241-99245, 99281-99285, 99341-99345, 99347-99350, 99384-99387, 99394-99397, 99401-99404, 99408, 99409, 99411, 99412, 99441-99444, 99510, HZ2ZZZZ ICD-10-CM Diagnosis F10.10 F10.120, F10.121, F10.129, F10.14, F10.150, F10.151, F10.159, F10.180-F10.182, F10.188,F10.19-F10.20, F10.220, F10.221, F10.229-F10.232, F10.239, F10.24, F10.250-F10.251, F10.259, F10.26, F10.27, F10.280-F10.282, F10.288, F10.29, F11.10, F11.120-F11.122, F11.129, F11.14, F11.150, F11.151, F11.159, F11.181, F11.182, F11.188, F11.19, F11.20, F11-220-F11.222, F11.229, F11.23, F11.24, F11.250, F11.251, F11.259, F11.281, F11.282, F11.288, F11.29, F12.10, F12.120-F12.122, F12.129, F12.150, F12.151, F12.159, F12.180, F12.188, F12.19, F12.20, F12.220-F12.222, F12.229, F12.250, F12.251, F12.259, F12.280, F12.288, F12.29, F13.10, F131.20, F13.121, F13.129, F13.14, F13.150, F13.151, F13.159, F13.180- F13.182, F13.188, F13.19, F13.20, F13.220, F13.221, F13.229-F13.232, F13.239, F13.24, F13.250, F13.251, F13.259, F13.26, F13.27, F13.280-F13.282, F13.288, F13.29, F14.10, F14.120-F14.122, F14.129, F14.14, F14.150, F14.151, F14.159, F14.180-F14.182, F14.188, F14.19, F14.20, F14.220-F14.222, F14.229, F14.23, F14.24, F14.250, F14.251, F14.259, F14.280-F14.282, F14.288, F14.29, F15.10, F15.120-F15.122, F15.129, F15.14, F15.150, F15.151, F15.159, F15.180- F15.182, F15.188, F15.19, F15.20, F15.220-F15.222, F15.229, F15.23, F15.24, F15.250, F15.251, F15.259, F15.280-F15.282, F15.288, F15.29, F16.10, F16.120-F16.122, F16.129, F16.14, F16.150, F16.151, F16.159, F16.180, F16.183, F16.188, F16.19, F16.20, F16.221, F16.229, F16.24, 16.250, F16.251, F16.259, F16.280, F16.283, F16.288, F16.29, F18.10, F18.120, F18.121, F18.129, F18.14, F18.150, F18.151, F18.159, F18.17, F18.180, F18.188, F18.19, F18.20, F18.220, F18.221, F18.229, F18.24, F18.250, F18.251, F18.259, F18.27, F18.280, F18.288, F18.29, F19.10, F19.120-F19.122, F19.129, F19.14, F19.150, F19.151, F19.159, F19.16, F19.17, F19.180, F19.181, F19.182, F19.188, F19.19, F19.20, F19.220-F19.222, F19.229-F19.232, F19.239, F19.24, F19.250, F19.251, F19.259, F19.26, F19.27, F19.280-F19.282, F19.288, F19.29 Codes to Identify Outpatient, Intensive Outpatient, Partial Hospitalization, Telehealth, and Medication Assisted Treatment (MAT) Visits (use these visit codes along with the one of the diagnosis codes above to capture initiation and engagement of AOD treatment H0001, H0002, H0004, H0005, H0010, H0020, H0031, H0034, H0039, H0047, H2010-H2020, H2035 0100, 0101, 0110-0154, 0156-0160, 0164, 0617, 0169-0174, 0179, 0190-0194, 0199-0204, 0206-0214, 0219, 0456, 0459, 0510, 0513, 0515-0517, 0519-0523, 0521, 0522, 0528, 0900, 0902-0907, 0911-0917, 0919, 0944, 0945, 0982, 0981, 0983, 1000-1002 90791, 90792, 90832-90834, 90836-90840, 90847, 90849, 90853 99221-99223, 99231-99233 CPT POS 02, 03, 05, 07, 09, 11, 12, 13, 14, 15,16,17,18,19, WITH 20, 22, 33, 49, 50, 52, 53, 57, 71, 72 WITH 02, 52, 53 Consider using screening tools or questions to identify substance abuse issues in patients. Document identified substance abuse in the patient chart and submit a claim with the appropriate codes, as described above. Avoid inappropriate use of diagnosis codes that are the result of alcohol or drug dependency (ex. Cirrhosis) as these also qualify patients for the measures. Schedule a follow-up visit within 14 days and at least two additional visits within 30 days, or refer immediately to a behavioral health provider when giving a diagnosis of alcohol or other drug dependence. Involve family members or others who the patient desires for support and invite their help in intervening with the patient diagnosed with AOD dependence. Provide patient educational materials and resources that include information on the treatment process and options. Work collaboratively with Molina case managers if they contact you about a recent encounters with a patient for substance dependency to motivate the patient to initiate treatment. Continue ongoing discussions with patients about treatment to help increase their willingness to commit to the process as the timeframe for initiating treatment is 14 days. Ensure your patient has an understanding of the local community support resources and what to do in an event of a crisis. Updated 1/5/18

Codes to Identify Follow -up Visits HEDIS Tips: Patients 6-12 years old, with a new prescription for an attention-deficit/hyperactivity disorder (ADHD) medication who had: Follow-up Care for Children Prescribed ADHD Medication At least one follow-up visit with practitioner with prescribing authority during the first 30 days of when the ADHD medication was dispensed. (Initiation Phase) At least two follow-up visits within 270 days (9 months) after the end of the initiation phase. One of these visits may be a telephone call. (Continuation and Maintenance Phase) Codes CPT: 96150-96154, 99078, 99201, 99204, 99211-99215, 99217-99220, 99241-99245, 99341-99345, 99347-99350, 99381-99384, 99391-99394, 99401 Follow-up Visits HCPCS: H0002, H0004, H0031, H0034, H0039, H2011, H2015, H2017 UB Revenue: 0516-0517, 0519-0523, 0526-0529, 0905, 0917, 0919, 0982, 0983 Codes Follow-up Visits CPT: 90791, 90792, 90832-90834, 90836-90839, 90845, 90847, 90849, 90853, 90875, 90876 CPT: 99221-99223, 99231-99233, 99238, 99239, 99251-99255 WITH WITH POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 22, 33, 49, 50, 52, 53, 71, 72 POS: 52, 53 Schedule a follow-up visit within 30 days to assess how the medication is working when prescribing a new medication to your patient. Schedule this visit while your patient is still in the office. Schedule two more visits in the nine months after the first 30 days to continue to monitor your patient s progress. Visits must be on different dates of service. Do not continue these controlled substances without at least two visits per year to evaluate a child s progress. If nothing else, you need to monitor the child s growth to make sure they are on the correct dosage. Refer patients for Health Management interventions and coaching by contacting Health Care Services at your affiliated Molina Healthcare state plan. Ensure the parents/guardians have an understanding of the local community support resources and what to do in an event of a crisis. Updated 1/5/18

Antidepressant Medication Management The percentage of adults 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remain on an antidepressant medication treatment. Two rates are reported: Effective Acute Phase Treatment: The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks). (Continuous treatment allows gaps in treatment up to a total of 30 days during the Acute Phase). Effective Continuation Phase Treatment: The percentage members who remained on an antidepressant medication for at least 180 days (six months). (Continuous treatment allows gaps intreatment up to a total of 51 days during the Acute and Continuation Phases combined). Codes to Identify Major Depression ICD-9 Codes *ICD-10 Codes Major Depression 296.20-296.25, 296.30-296.35, 298.0, 311 F32.0-F32.4, F32.9, F33.0- F33.3. F33.41, F33.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. ANTIDEPRESSANT MEDICATIONS Generic Name Brand Name Miscellaneous antidepressants Buproprion Vilazodone Vortioxetine Wellbutrin ; Zyban Viibryd Brintellix Phenylpiperazine antidepressants Psychotherapeutic combinations SNRI antidepressants SSRI antidepressants Tetracyclic antidepressants Tricyclic antidepressants Monoamine oxidase inhibitors Nefazodone Trazodone Amitriptylinechlordiazepoxide; Amitriptylineperphenazine; Fluoxetineolanzapine Desvenlafaxine Levomilnacipran Duloxetine Venlafaxine Citalopram Escitalopram Fluoxetine Fluvoxamine Paroxetine Sertraline Maprotiline Mirtazapine Amitriptyline Amoxapine Clomipramine Desipramine Doxepin (>6mg) Imipramine Nortriptyline Protriptyline Trimipramine Isocarboxazid Phenelzine Selegiline Tranylcypromine Serzone Desyrel Limbitrol Triavil ; Etrafon Symbax Pristiq Cymbalta Effexor Celexa Lexapro Prozac Luvox Paxil Zoloft Ludiomil Remeron Elavil Asendin Anafranil Norpramin Sinequan Tofranil Pamelor Vivactil Surmontil Marplan Nardil Anipryl ; Emsam Parnate Educate patients on the following: o Depression is common and impacts 15.8 million adults in the United States. o Depression can be treated. Most antidepressants take between one and six weeks to work before the patient starts to feel better. o In many cases, sleep and appetite improve first while improvement in mood, energy and negative thinking may take longer. o The importance of staying on the antidepressant for a minimum of six months. o Strategies for remembering to take the antidepressant on a daily basis. o The connection between taking an antidepressant and signs and symptoms of improvement. o Common side effects, how long the side effects may last and how to manage them. o What to do if the patient has a crisis or has thoughts of self-harm. o What to do if there are questions or concerns. Contact Health Care Services at your affiliated Molina Healthcare State plan for additional information about Medication Therapy Management (MTM) criteria and to request a referral for patients with at least six (6) chronic medications and at least three (3) qualifying diagnoses. They may be eligible for MTM sessions. Updated 1/5/18

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who are Using Antipsychotic Medications Adults 18-64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test (glucose test or HbA1c test) during the measurement year. Codes to Identify Diabetes Screening Codes to Identify Glucose Tests Codes to Identify HbA1c Tests USE CORRECT BILLING CODES Codes CPT: 80047, 80048, 80053, 80069, 82947, 82950, 82951 CPT: 83036, 83037 CPT II: 3044F (if HbA1c<7%), 3045F (if HbA1c 7%-9%), 3046F (if HbA1c>9%) Antipsychotic Medications Generic Name Brand Name Miscellaneous antipsychotic agents Aripiprazole, Asenapine, Brexpiprazole, Cariprazine, Clozapine, Haloperidol, Iloperidone, Loxapine, Lurisadone, Molindone, Olanzapine, Paliperidone, Pimozide, Quetiapine, Quetiapine fumarate, Risperidone, Ziprasidone Chlorpromazine, Fluphenazine, Perphenazine, Prochlorperazine, Thioridazine, Trifluperazine Fluoxetine-olanzapine Perphenazine-amitriptyline, Abilify, Saphris, Rexulti, Vraylar, Clozaril, Haldol, Fanapt, Loxipac/Loxitane, Latuda, Moban, Zyprexa, Invega, Orap, Seroquel, Seroquel XR, Risperdal, Geodon Phenothiazine antipsychotics Thorazine, Prolixin,, Etrafon, Compazine, Mellaril, Stelazine Psychotherapeutic Symbyax combinations Trilafon Thioxanthenes Thiothixene Navane Long-acting injections Aripiprazole, Fluphenazine decanoate, Haloperidol decanoate, Olanzapine, Paliperidone palmitate, Risperidone Abilify Maintena, Prolixin, Haldol Decanoate INJ, Zyprexa Relprew, Invega Sustenna, Risperdal Consta Help patients with scheduling a follow-up appointment in between one to three months with their PCPs to screen for diabetes. If the patient is not ready to schedule appointment, make note or flag chart to contact the patient with a reminder to schedule an appointment. Ensure patient (and/or caregiver) is aware of the risk of diabetes and have awareness of the symptoms of new onset of diabetes while taking antipsychotic medication. Schedule lab screening tests through PCP prior to next appointment. The BH provider can order diabetic lab tests for patients who do not have regular contact with their PCP but who regularly see the BH provider. The BH provider can then coordinate medical management with the PCP. Patients can be referred for Health Management interventions and coaching by contacting Health Care Services at your affiliated Molina Healthcare state plan. Ensure your patient has an understanding of the local community support resources and what to do in an event of a crisis. Updated 12/28/17

HEDIS Sheets Older Preventive Health Care for Older Adults Osteoporosis Management in Women Who Had a Fracture Colorectal Cancer Screening

Care for Older Adults The percentage of adults 66 years and older who had each of the following during the measurement year: Advance care planning (e.g. living will, health care power of attorney, healthcare proxy). Medication review by a prescribing practitioner or clinical pharmacist and presence of a medication list. Functional status assessment (e.g., ADLs or IADLs). Pain assessment (e.g., pain inventory, numeric scale, faces pain scale). Notation of screening or documentation for chest pain alone does not count. Advance Care Planning Medication Review Medication List Functional Status Assessment Pain Assessment Codes CPT: 99497 CPT II: 1123F, 1124F, 1157F, 1158F HCPCS: S0257 CPT:, 90863, 99605, 99606 CPT II: 1160F CPT II: 1159F HCPCS: G8427 CPT II: 1170F CPT II: 1125F, 1126F TCM14 Day CPT: 99495 TCM7 day CPT: 99496 Updated 2/26/2018 Use the Annual Comprehensive Exam (ACE) form from Molina Healthcare to capture these assessments if patient is eligible. Document advance care planning discussion with the provider and the date when it was discussed. Be sure to include evidence of a complete functional status assessment. Documentation that the patient was assessed for pain (which may include positive or negative findings for pain) and document result of assessment using a standardized pain assessment tool. Use the Medicare Stars checklist tool for reference and to place on top of chart as a reminder to complete. Remember that the medication review measure requires that the medications are listed in the chart, plus the review. Incorporate a standardized template to capture these measures for Members 66 years and older if on EMR. Use Molina Healthcare s ACE form as a guide.

Osteoporosis Management for Fractures Women 67-85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat or prevent osteoporosis in the six (6) months after the fracture. Codes to Identify Bone Mineral Density Test and Osteoporosis Medications Codes CPT: 76977, 77078, 77080, 77081, 77085, 77086 HCPCS: G0130 *ICD-9: 88.98 Bone Mineral ICD-10: BP48ZZ1, BP49ZZ1, BP4GZZ1, BP4HZZ1, Density Test BP4LZZ1, BP4MZZ1, BP4NZZ1, BP4PZZ1, BQ00ZZ1, BQ01ZZ1, BQ03ZZ1, BQ04ZZ1, BR00ZZ1, BR07ZZ1, BR09ZZ1, BR0GZZ1 Osteoporosis Medications Long-Acting Osteoporosis Medications (for inpatient stays only) HCPCS: J0630, J0897, J1740, J3489 HCPCS: J0897, J1740, J3489 * ICD-9 codes are included for historical purposes only and can no longer be used for billing. Osteoporosis Therapies Prescription Alendronate Ibandronate Biphosphonates Alendronate-cholecalciferol Risedronate Zoledronic acid Other agents Calcitonin Raloxifene Denosumab Teriparatide Order a BMD test on all women with a diagnosis of a fracture within six (6) months OR prescribe medication to prevent osteoporosis (e.g., bisphosphonates). Educate patient on safety and fall prevention. Note, aggressive risk adjustment can overstate osteoporosis by confusing lower Z scores / osteopenia with osteoporosis. Updated 2/27/2018

Patients 50-75 years of age who had one of the following screenings for colorectal cancer screening: gfobt or ifobt (or FIT) with required number of samples for each test during the measurement year, or Flexible sigmoidoscopy during the measurement year or the four years prior to the measurement year, or Colonoscopy during the measurement year or the nine years prior to the measurement year. CT colonography during the measurement year or the four years prior to the measurement year. FIT-DNA test during the measurement year or the two years prior to the measurement year. Required Exclusion: Medicare patients age 65 and older as of January 1 of the measurement year who enrolled in an institutional SNP live in a long-term institution any time during the measurement year. Note: FOBT tests performed in an office or performed on a sample collected via a digital rectal exam (DRE) do not meet criteria. Exclusions: Colorectal cancer or total colectomy Codes to Identify Colorectal Cancer Screening FIT-DNA CPT: 81528 HEDIS Tips: Colorectal Cancer Screening FOBT CPT: 82270, 82274 HCPCS: G0328 Codes Flexible Sigmoidoscopy Colonoscopy CPT: 45330-45335, 45337, 45388, 45340-4532, 45347, 45349, 45350 HCPCS: G0104 *ICD-9: 45.24 CPT: 44388-44392,44394, 44401-44408, 45378-45382, 45384-45386, 45388-45393, 45398 HCPCS: G0105, G0121 *ICD-9: 45.22, 45.23, 45.25, 45.42, 45.43 CT Colonography CPT: 74261, 74262 Codes to Identify Optional Exclusions Codes Colorectal Cancer *ICD-9-CM: 153.0-153.9, 154.0, 154.1 197.5, V10.05, V10.06 ICD-10 CM: C18.0-C18.9, C19, C20, C21.2, C21.8, C78.5, Z85.038, Z85.048 CPT: 44150, 44151, 44155-44158, 44210-44212 Total Colectomy *ICD-9: 45.81, 45.82, 45.83 ICD-10 PCS: 0DTE0ZZ, 0DTE4ZZ, 0DTE7ZZ, 0DTE8ZZ *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Update patient history annually regarding colorectal cancer screening (test done and a date). Encourage patients who are resistant to having a colonoscopy to have a stool test that they can complete at home (either gfobt or ifobt). The ifobt/fit has fewer dietary restrictions and samples. Use standing orders and empower office staff to distribute FOBT or FIT kits to patients who need colorectal cancer screening or prepare referral for colonoscopy. Follow-up with patients. Clearly document patients with ileostomies, which implies colon removal (exclusion), and patients with a history of colon cancer (more and more frequent). Updated 2/23/18

HEDIS Sheets Respiratory Health Medication Management for People with Asthma - 75% Compliance Use of Spirometry Testing in the Assessment and Diagnosis of COPD Pharmacotherapy for Management of COPD Exacerbation Bronchodilators

Medication Management for People with Asthma The percentage of patients 5 64 years of age during the measurement year who were identified as having persistent asthma and were dispensed appropriate medications that they remained on during the treatment period. Two rates are reported: 1. The percentage of patients who remained on an asthma controller medication for at least 50 percent of their treatment period. 2. The percentage of patients who remained on an asthma controller medication for at least 75 percent of their treatment period. Patients are in the measure if they met at least one of the following during both the measurement year and the year prior. At least one ED visit with asthma as the principal diagnosis. At least one acute inpatient claim/encounter, with asthma as the principal diagnosis. At least four (4) outpatient asthma visits with asthma as one of the diagnoses and at least two (2) asthma medication dispensing events for any controller medication. At least four (4) asthma medication dispensing events for any controller medication or reliever medication. If leukotriene modifiers were the sole asthma medication dispensed, there must also be at least one diagnosis of asthma, in any setting, in the same year as the leukotriene modifier (i.e., measurement year or the year prior.) Codes to Identify Asthma Asthma *ICD-9 Codes ICD-10 Codes 493.00-493.02, 493.10-493.12, 493.20-493.22, 493.81, 493.82, 493.90-493.92 Mild Intermittent Asthma J45.20, J45.21, J45.22 Mild Persistent Asthma J45.30, J45.31, J45.32 Moderate Persistent Asthma J45.40, J45,41, J45.42 Severe Persistent Asthma J45,50, J45,51, J45.52 Other and Unspecified Asthma J45.901, J45.902, J45.909, J45.990, J45.991, J45.998 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Asthma Controller Medications Prescriptions Antiasthmatic combinations Anti-interleukin-5 Antibody inhibitor Inhaled steroid combinations Inhaled corticosteroids Dyphylline-guaifenesin, Guaifenesin-theophylline Mepolizumab, Resilzumab Omalizumab Budesonide-formoterol, Fluticasone-salmeterol, Fluticasone-vilanterol, Mometasone-formoterol Beclomethasone, Budesonide, Ciclesonide, Flunisolide, Fluticasone CFC free, Mometasone Leukotriene modifiers Mast cell stabilizers Methylxanthines Updated 2/23/18 Montelukast, Zafirlukast, Zileuton Cromolyn Aminophylline, Dyphylline, Theophylline *Please refer to the Molina Healthcare Drug Formulary at www.molinahealthcare.com for asthma controller medications that may require prior authorization or step therapy. Ensure proper coding to avoid coding asthma if not formally diagnosing asthma and only asthma-like symptoms were present. Ex: wheezing during viral URI and acute bronchitis is not asthma. Educate patients on use of asthma medications and importance of using asthma controller medications daily. Prescribe a long-term controller medication and provide reminders to your patients to fill controller medications. Remind Molina patients that mail-order delivery is available Refer patients for Health Management interventions and coaching by contacting Health Care Services at your affiliated Molina Healthcare state plan.

Spirometry Testing in COPD Assessment Patients 40 years of age and older with a new diagnosis of COPD or newly active COPD, who received spirometry testing to confirm the diagnosis in the two (2) years prior to the diagnosis or within six (6) months of the diagnosis. Codes to Identify COPD *ICD-9 CM Diagnosis ICD-10 CM Diagnosis Chronic bronchitis 491.0, 491.1, 491.20-491.22, 491.8, 491.9 J41.0, J41.1, J41.8, J42 Emphysema 492.0, 492.8 J43.0, J43.1, J43.2, J43.8, J43.9 COPD 493.20, 493.21, 493.22, 496 J44.0, J44.1, J44.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Codes to Identify Spirometry Testing CPT Codes Spirometry 94010, 94014-94016, 94060, 94070, 94375, 94620 Follow the standard of care and use spirometry testing for diagnosing COPD. Perform spirometry test on patients newly diagnosed with COPD within 180 days to confirm diagnosis of COPD, evaluate severity, and assess current therapy. Note: If the patient had a spirometry performed in the previous two years to confirm the new diagnosis of COPD in the first place, they do not need a repeat. Ensure appropriate documentation of spirometry testing. Perform spirometry in office if equipment available. If equipment is not available in your office, arrange for patient to get the test completed at a location with spirometry equipment, for example, a pulmonology unit. Differentiate acute from chronic bronchitis and use correct code so that patient is not inadvertently put into the measure. Review problem lists and encounter forms and remove COPD / chronic bronchitis when the diagnosis was made in error. Updated 2/26/2018

Pharmacotherapy Management of COPD Exacerbation The percentage of COPD exacerbations for patients 40 years and older who had an acute inpatient discharge or ED visit with a primary diagnosis of COPD, emphysema or chronic bronchitis on or between January 1 November 30 of the measurement year and were dispensed appropriate medications: A systemic corticosteroid (or there was evidence of an active prescription) within 14 days of the event A bronchodilator (or there was evidence of an active prescription) within 30 days of the event Codes to Identify COPD, Emphysema, or Chronic Bronchitis Prescription COPD *ICD9: 493.20, 493.21, 493.22, 496 ICD-10: J44.0, J44.1, J44.9 Emphysema *ICD9: 492.0, 492.8, 518.1, 518.2 ICD-10: J43.0, J43.1, J43.2, J43.8, J43.9 *ICD9: 491.0, 491.1, 491.2, ICD-10: J41.0, J41.1, J41.8, J42 Chronic Bronchitis 491.8, 491.9 *ICD-9 codes are included for historical purposes only and can no longer be used for billing. Systemic Corticosteroids Glucocorticoids Bronchodilators Anticholinergic agents Beta 2-agonists Methylxanthines Antiasthmatic combinations Prescription Betamethasone Hydrocortisone Prednisolone Triamcinolone Dexamethasone Methylprednisolone Prednisone Cortisone-acetate Prescription Albuterol-ipratropium Ipratropium Umeclidinium Aclidinium-bromide Tiotropium Albuterol Formoterol-glycopyrrolate Olodaterol hydrochloride Arformoterol Indacaterol Olodaterol-tiotropium Budesonide-formoterol Indacaterol-glycopyrrolate Pirbuterol Fluticasone-salmeterol Levalbuterol Salmeterol Fluticasone-vilanterol Mometasone-formoterol Umeclidinium-vilanterol Formoterol Aminophylline Dyphylline-guaifenesin Metaproterenol Dyphylline Theophylline Guaifenesin-theophylline Schedule a follow-up appointment within 7-14 days of discharge. Consider standing orders for those patients discharged from the hospital or emergency room. Contact your patient once they have been discharged to schedule a follow-up appointment as soon as possible. Remind patients to fill their corticosteroid and bronchodilator prescriptions. Refer to Molina s adopted clinical practice guidelines on COPD via the Molina website. Updated 2/26/2018

Partnering with Molina The Molina Quality (QI) Department can partner with your organization in the following ways: Serve as a partner to help host or create health events to close gaps in care Analysis of care gaps and list of Members needing required services Claims review Coordination of secure data feeds and EMR system access Assistance to Members with securing transportation to appointments Development and dissemination of outreach communications and reminders to your patients who need to complete important medical checks Access to and coaching on the use of the Provider Portal to upload records Dedicated QI Interventionists and MRR Staff to assist with the following: HEDIS Incentive Program reports and scorecard updates Coaching on closing gaps in care Provision of tip sheets and measure guides with measure details Review of medical records to assess services Training on measures Participation in meetings with providers, executive level staff, midrange staff to provide overviews of performance and recommended actions

Next Steps Sign up for the Provider Portal at https://provider.molinahealthcare.com/provider/login Reach out to your Provider Network Manager if you need access and/or training on using the Provider Portal Provider Network Services Department (630) 203-3965 or via email IllinoisProviders@MolinaHealthcare.com. Discuss remote EMR access requirements and set up with your IT and Compliance teams to make the process of medical record review seamless with Molina Healthcare of Illinois. Set a meeting with the QI Interventions staff about your P4P measures and possible intervention activities Set up an outreach and screening event to close gaps in care Set up a meeting with QI Medical Record Review staff to discuss best practices for charting and documentation of services

Key Terms and Acronyms Abstracting Process of collecting detailed information from a medical record (MRR) CPT Current Procedural Terminology is a series of five-digit codes describing services Collection Year Year HEDIS services are rendered year prior to the measurement/ reporting year. Denominator Population used to report a measure EMR Electronic Medical Record, EHR DRG Diagnosis-Related Groups - 3 digit codes describing hospital stays ICD-10-CM International Classification of Diseases, 10th Revision, Clinical Modification - New coding system that will replace ICD-9 CM effective October 1, 2014, HIPAA requirement, variable length IRR Inter-Rater Reliability procedure(s)/quality control check to ensure that the medical record review process is being done correctly and in a standard fashion across reviewers Look Back Period Years prior to the Collection Year that services can occur and be credited for HEDIS Measurement Year Year HEDIS Data is reported Reporting Year Modifier Code suffix that provides further clarification on the practitioner or service type on a claim. NCQA National Committee for Quality Assurance Numerator The number of Members in the denominator who met the measure criteria using system and transactional data alone or with medical record data P4P Pay-for-performance Reporting Year The year in which HEDIS is reported and for which the volume is named; the year immediately following the measurement year Retrospective In the past - way in which HEDIS reviews are conducted (review of programs, processes and services in the prior year) Rev Code Revenue Code, 3 or 4 digit code describing services SFTP File Transfer Protocol - Secure Site SDS Supplement Data Sources Administrative data sources, both internal and external, used for HE- DIS data reporting. Must be approved by auditor. Information from any source except transaction systems

Quality Service Department For HEDIS measure inquiries and medical record review. Quality Interventions 855) 866-5462 Fax: (866) 617-4969 QIHEDISDivision@MolinaHealthcare.com Fax: (844) 479-5341 Quality-HealthCampaigns@MolinaHealthcare.com Behavioral Health (855) 866-5462 24-Hour Crisis Hotline: (888) 275-8750 24-Hour Spanish Crisis Hotline: (866) 648-3537 Member Services Department For Member inquiries, including benefits, eligibility, changing PCPs and complaints HealthChoice Illinois: (855) 866-5462 MMP: (877) 901-8181 TTY: 711 Provider Services Department For provider inquiries regarding address or Tax ID updates, denied claims, contracting and training on Molina Healthcare policies (855) 866-5462 IllinoisProviders@MolinaHealthcare.com Utilization Management For Prior Authorization requests and questions (855) 866-5462 Fax: (866) 617-4971 Pharmacy Department For questions about our preferred drug list, prior authorization for prescription drugs or to find a network pharmacy Medicaid: (855) 866-5462 MMP: (877) 901-8181 Medicaid Fax (855) 365-8112 MMP Fax: (866) 290-1309 *MMP is an abbreviation for Medicare-Medicaid Plan (Molina Dual Options)